IE000B9PQW54
IE000B9PQW54
VanEck Genomics and Healthcare Innovators UCITS ETF
Loading chart...
About this ETF
The VanEck Genomics and Healthcare Innovators UCITS ETF A seeks to track the MVIS Global Future Healthcare ESG index. The MVIS Global Future Healthcare ESG index tracks companies worldwide that are active in the genomics or e-healthcare industries. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
TER
0.35%
Total Expense Ratio per year
Fund Size
€21.69M
Assets under management
Holdings
49
Underlying equities
Dividend Yield
-
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
28.87
Weighted Fwd P/E
70.78
💰 Revenue Estimates
Current Year CY
+14.59% ⌀ 19 Analysts Coverage
Next Year NY
+37.26% ⌀ 19 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-817.92% ⌀ 16 Analysts Coverage
Next Year NY
+42.1% ⌀ 15 Analysts Coverage
Related ETFs
VanEck Medical Robotics and Bionic Engineering UCITS ETF
15.54 CHF
TER 0.55% 1Y -6.4%
Xtrackers World Green Tech Innovators UCITS ETF 1C
35.23 EUR
TER 0.35% 1Y +15.2%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
43.65 USD
TER 0.3% 1Y +62.3%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
09/02/2022 (4 yrs)
Index Group
MVIS Thematic Region
World Country
-
Sector
Health Care Strategy
Social / Environmental Theme
Innovation Distribution Policy
Accumulating Replication
Full replication Sustainable
Yes 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
—
Diversification Score: 27/100 Low (Concentration Risk)
Diversification Score
27/100 Low (Concentration Risk)
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Notes & Warnings
Fund Volume (AUM) ⚠️ Fund closure risk (< 50M € AUM)
⚠️ Fund closure risk (< 50M € AUM)
🟡 Moderate analyst coverage (16.4 analysts)
🔴 Extreme top 10 holdings concentration: 60% of fund in top 10 positions.
🔴 Severe sector concentration risk: 100% in "Healthcare".
⚠️ Industry concentration: 46% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).